Omnitrope’s Efficacy in Enhancing Growth in Children with Congenital Heart Disease
Reading Time: 2 minutesIntroduction Congenital heart disease (CHD) remains a significant health concern among pediatric populations, often leading to growth retardation and developmental delays. In the quest to mitigate these effects, recombinant human growth hormone (rhGH) therapies, such as Omnitrope, have emerged as a beacon of hope. This article delves into the efficacy of Omnitrope in children diagnosed with CHD, focusing on its... Read more »